乳腺癌区域淋巴结放疗中质子与光子对肺组织反应及患者结局的差异:一项随机试验内的前瞻性相关性研究
该前瞻性相关性研究纳入91例乳腺癌区域淋巴结放疗患者,比较质子与光子治疗后的肺密度变化。质子治疗的TD₅₀显著低于光子,提示更高的辐射敏感性,RBE在1.24-1.35之间,但两组临床肺炎和纤维化发生率无差异。
要点
- 质子治疗肺密度变化的TD₅₀低于光子,RBE约1.24-1.35。
- 质子治疗HU变化出现更早,但未增加临床肺炎或纤维化。
- 咳嗽和呼吸困难发生率两组相似,HU变化与症状无相关性。
核心结论
- 尽管临床肺部结局相当,质子治疗较光子治疗引起更明显的亚临床肺组织变化。
研究设计与样本
- 前瞻性收集91例乳腺癌区域淋巴结放疗患者的系列平扫CT,其中71例有完整随访影像(质子36例,光子35例)。
- 患者于2017至2023年在麻省总医院同时入组随机临床试验和相关性亚研究。
- 采用变形配准计划与随访CT,按剂量分箱分析同侧肺HU变化,使用Lyman-Kutcher-Burman模型估算TD₅₀和斜率m。
- 采用10,000次迭代的Bootstrap分析确定置信区间和统计学显著性。
主要发现
- 右侧自由呼吸队列8.5个月时质子TD₅₀为33.4 Gy(RBE),光子为45.1 Gy,RBE为1.35(95%CI 1.18-1.44),第二次随访降至1.27(95%CI 1.14-1.36)。
- 总体人群第一次随访质子TD₅₀为34.5 Gy(RBE),光子为43.6 Gy,RBE为1.27(95%CI 1.14-1.33),第二次随访降至1.24(95%CI 1.12-1.33)。
- 质子治疗HU变化出现更早,但TD₅₀值与患者肺毒性无显著关联。
- 无患者出现临床相关肺炎或纤维化,两组咳嗽和呼吸困难发生率相似(P > .40),HU变化与症状无相关性。
关键数值与推荐
- 质子治疗TD₅₀低于光子治疗,提示更高的辐射敏感性,RBE范围为1.24-1.35。
- 未发现显著混杂因素。
临床怎么用
- 质子治疗乳腺癌区域淋巴结放疗时需关注亚临床肺组织变化,尽管临床肺炎风险未增加。
- 支持在质子治疗计划中评估基于传能线密度和RBE的优化策略。
- 需个体化考虑RBE变异性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this paper is to quantify radiation-induced lung density changes in patients with breast cancer treated with proton therapy and compare the effect to photon therapy, assessing both temporal dynamics and spatial distribution of these changes. METHODS AND MATERIALS: We prospectively collected serial noncontrast computed tomography scans on a cohort of 91 patients at 6- and 12-month post-radiation therapy. All patients were co-enrolled on a randomized clinical trial and a correlative substudy at Massachusetts General Hospital between 2017 and 2023. Deformably registered planning and follow-up (FU) computed tomography scans were analyzed using voxel-wise Hounsfield unit (HU) changes binned by dose (5 Gy relative biological effectiveness [RBE] increments) within the ipsilateral lung. Dose-response relationships were modeled using the Lyman-Kutcher-Burman model to estimate the dose associated with 50% of the observed maximum lung density changes in HU (TD₅₀) and slope (m) parameters as comparative metrics between modalities. Bootstrap analysis with 10,000 iterations was used to determine confidence intervals and assess statistical significance. RBE was calculated as the ratio of photon to proton TD₅₀ values per voxel. Demographic and clinical variables were tested to rule out confounding. RESULTS: A total of 71 patients had complete FU imaging (36 protons and 35 photons). Proton therapy demonstrated significantly lower TD₅₀ values than photon therapy at both FU visits, indicating greater radiation sensitivity. The right-sided free-breathing cohorts showed TD₅₀ of 33.4 Gy(RBE) for protons versus 45.1 Gy for photons at 8.5 months, with RBE of 1.35 (95% CI, 1.18-1.44), decreasing to 1.27 (95% CI, 1.14-1.36) at second follow-up. The overall population showed TD₅₀ of 34.5 Gy(RBE) for protons versus 43.6 Gy for photons at first follow-up with an RBE of 1.27 (95% CI, 1.14-1.33), decreasing to 1.24 (95% CI, 1.12-1.33) at second follow-up. No significant confounders were identified. Temporal analysis revealed an earlier onset of HU changes with protons, but there were no significant associations between patient pulmonary toxicities and TD50 values. No patients developed clinically relevant pneumonitis or fibrosis. Cough and dyspnea rates were similar between groups (P > .40), with no correlations between HU changes and symptoms. CONCLUSIONS: Despite equivalent clinical pulmonary outcomes, proton therapy demonstrates greater subclinical lung tissue changes than photon therapy. These findings support ongoing evaluation of potentially linear energy transfer- and RBE-based optimization strategies in proton therapy planning and highlight the need for personalized approaches accounting for RBE variability.
引用
- Salome P, Shah KD, Todorova P, et al. Differential Lung Tissue Response and Patient Outcomes Between Protons and Photons Receiving Regional Nodal Irradiation for Breast Cancer: A Prospective Correlative Study withina Randomized Trial. Int J Radiat Oncol Biol Phys. 2026. PMID: 42526652. doi:10.1016/j.ijrobp.2026.07.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。